Use of IL-1 inhibitors and TNF antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia
A Standard patent application filed on 13 October 2006 credited to McCabe, Dorothy
;
Newmark, Richard
;
Coccia, Marco A.
;
Kay, Jonathan
Details
Application number :
2006228063
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Use of IL-1 inhibitors and TNF antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia
Inventor :
McCabe, Dorothy
;
Newmark, Richard
;
Coccia, Marco A.
;
Kay, Jonathan
Agent name :
Shelston IP
Address for service :
Level 21 60 Margaret Street Sydney NSW 2000 Australia
Filing date :
13 October 2006
Associated companies :
Applicant name :
Amgen Inc.
Applicant address :
One Amgen Center Drive Thousand Oaks California 91320-1799 United States of America